IMMUNOTAC Trademark

Trademark Overview


On Friday, September 7, 2018, a trademark application was filed for IMMUNOTAC with the United States Patent and Trademark Office. The USPTO has given the IMMUNOTAC trademark a serial number of 88108634. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by Silverback Therapeutics, Inc.. The IMMUNOTAC trademark is filed in the Pharmaceutical Products category with the following description:

Systemically delivered, locally active immune modulatory conjugates in the nature of pharmaceuticals, including biopharmaceuticals, pharmaceutical preparations, including biopharmaceutical preparations, agents, namely, biopharmaceutical and pharmaceutical preparations and substances, and medicines for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases; pharmaceuticals and pharmaceutical preparations of systemically delivered, locally active immune modulatory conjugates for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases; engineered immunomodulatory therapeutics in the nature of pharmaceuticals, including biopharmaceuticals, pharmaceutical preparations, including biopharmaceutical preparations, agents, namely, biopharmaceutical and pharmaceutical preparations and substances, and medicines for use in the treatment of cancer, oncological disorders, a...
immunotac

General Information


Serial Number88108634
Word MarkIMMUNOTAC
Filing DateFriday, September 7, 2018
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6200968
Registration DateTuesday, November 17, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements


Goods and ServicesSystemically delivered, locally active immune modulatory conjugates in the nature of pharmaceuticals, including biopharmaceuticals, pharmaceutical preparations, including biopharmaceutical preparations, agents, namely, biopharmaceutical and pharmaceutical preparations and substances, and medicines for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases; pharmaceuticals and pharmaceutical preparations of systemically delivered, locally active immune modulatory conjugates for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases; engineered immunomodulatory therapeutics in the nature of pharmaceuticals, including biopharmaceuticals, pharmaceutical preparations, including biopharmaceutical preparations, agents, namely, biopharmaceutical and pharmaceutical preparations and substances, and medicines for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 15, 2018
Primary Code005
First Use Anywhere DateFriday, June 26, 2020
First Use In Commerce DateFriday, June 26, 2020

Trademark Owner History


Party NameSilverback Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Party NameSilverback Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Party NameSilverback Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events


Event DateEvent Description
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, October 14, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 13, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 22, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 8, 2020USE AMENDMENT FILED
Tuesday, September 22, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 8, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, April 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 8, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, July 8, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, July 8, 2019FINAL REFUSAL E-MAILED
Monday, July 8, 2019FINAL REFUSAL WRITTEN
Wednesday, June 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 31, 2018LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Friday, December 28, 2018LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, December 19, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 19, 2018NON-FINAL ACTION E-MAILED
Wednesday, December 19, 2018NON-FINAL ACTION WRITTEN
Tuesday, December 18, 2018ASSIGNED TO EXAMINER
Saturday, September 15, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 11, 2018NEW APPLICATION ENTERED IN TRAM